Woodline Partners’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50.7M | Buy |
|
|||||
|
2025
Q2 | $30.9M | Buy |
|
|||||
|
2025
Q1 | $693K | Buy |
|
|||||
|
2024
Q4 | $1.22M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $2.99M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.81M | Sell |
|
|||||
|
2023
Q2 | $875K | Sell |
|
|||||
|
2023
Q1 | $1.43M | Sell |
|
|||||
|
2022
Q4 | $2.65M | Sell |
|
|||||
|
2022
Q3 | $1.81M | Hold |
|
|||||
|
2022
Q2 | $2.27M | Hold |
|
|||||
|
2022
Q1 | $3.79M | Buy |
|
|||||
|
2021
Q4 | $5.47M | Sell |
|
|||||
|
2021
Q3 | $6.47M | Sell |
|
|||||
|
2021
Q2 | $5.73M | Hold |
|
|||||
|
2021
Q1 | $5.6M | Hold |
|
|||||
|
2020
Q4 | $5.76M | Buy |
|
|||||
|
2020
Q3 | $5.18M | Buy |
|